We are live on
!
Find out more
PLC
Peapod Lane Capital Portfolio holdings
AUM
$148M
1-Year Est. Return
89.92%
This Fund
S&P 500
This Quarter
Est. Return
+27.69%
1 Year Est. Return
+89.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$148M
AUM Growth
+$26.3M
(+22%)
Cap. Flow
+$6.69M
Cap. Flow
% of AUM
4.52%
Top 10 Holdings %
Top 10 Hldgs %
32.18%
Holding
69
New
7
Increased
42
Reduced
12
Closed
8
Avg Time Held
4
quarters
Top 10 Avg Time Held
1.9
quarters
Top 20 Avg Time Held
2.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
enGene Therapeutics
ENGN
|
+$4.49M |
| 2 |
Pure Cycle
PCYO
|
+$2.04M |
| 3 |
Bicycle Therapeutics
BCYC
|
+$1.91M |
| 4 |
Bassett Furniture
BSET
|
+$1.84M |
| 5 |
Fulcrum Therapeutics
FULC
|
+$1.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Commercial Vehicle Group
CVGI
|
+$2.28M |
| 2 |
4D Molecular Therapeutics
FDMT
|
+$2.21M |
| 3 |
Fonar
FONR
|
+$2.11M |
| 4 |
Twin Disc
TWIN
|
+$1.62M |
| 5 |
KVH Industries
KVHI
|
+$1.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.12% |
| 2 | Healthcare | 19.35% |
| 3 | Consumer Discretionary | 16.44% |
| 4 | Real Estate | 9.39% |
| 5 | Consumer Staples | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Hurco Companies Inc
HURC
$138M
| $6.06M | 4.09% |
264,792
+19,924
| +8% | +$359K |
2024 Q4
6 quarters
|
|
2
Chatham Lodging
CLDT
$637M
| $6.05M | 4.08% |
457,149
+7,128
| +2% | +$73.7K |
2025 Q1
5 quarters
|
|
3
Alico
ALCO
$286M
| $4.86M | 3.28% |
117,439
-16,253
| -12% | -$674K |
2024 Q4
6 quarters
|
|
4
Acacia Research
ACTG
$424M
| $4.64M | 3.13% |
994,770
-96,566
| -9% | -$464K |
2024 Q4
6 quarters
|
|
5
Fulgent Genetics
FLGT
$591M
| $4.6M | 3.1% |
224,207
+3,580
| +2% | +$60.7K |
2024 Q4
6 quarters
|
|
6
Clearwater Paper
CLW
$301M
| $4.55M | 3.07% |
289,906
+75,385
| +35% | +$1.14M |
2025 Q1
5 quarters
|
|
7
Limoneira
LMNR
$221M
| $4.48M | 3.02% |
340,880
+92,537
| +37% | +$1.19M |
2025 Q2
4 quarters
|
|
8
OraSure Technologies
OSUR
$270M
| $4.43M | 2.99% |
993,875
-24,601
| -2% | -$87K |
2024 Q4
6 quarters
|
|
9
Trueblue
TBI
$268M
| $4.19M | 2.83% |
601,005
-39,005
| -6% | -$217K |
2025 Q1
5 quarters
|
|
10
AerSale
ASLE
$237M
| $3.84M | 2.59% |
607,358
+110,484
| +22% | +$722K |
2024 Q4
6 quarters
|
|
11
DELISTED
AstroNova
ALOT
| $3.79M | 2.56% |
133,065
+2,087
| +2% | +$33.4K |
2024 Q4
6 quarters
|
|
12
Star Holdings Shares of Beneficial Interest
STHO
$100M
| $3.77M | 2.54% |
412,468
+6,495
| +2% | +$56.1K |
2024 Q4
6 quarters
|
|
13
Seneca Foods Class A
SENEA
$1.24B
| $3.59M | 2.42% |
20,648
+356
| +2% | +$52.9K |
2024 Q4
6 quarters
|
|
14
Hooker Furnishings Corp
HOFT
$134M
| $3.48M | 2.35% |
195,224
+3,064
| +2% | +$41.9K |
2024 Q4
6 quarters
|
|
15
Johnson Outdoors
JOUT
$449M
| $3.07M | 2.07% |
66,748
+1,069
| +2% | +$50.8K |
2024 Q4
6 quarters
|
|
16
Seaport Entertainment Group
SEG
$285M
| $2.92M | 1.97% |
109,851
+17,345
| +19% | +$408K |
2026 Q1
1 quarter
|
|
17
UNIFI
UFI
$112M
| $2.76M | 1.87% |
581,977
+9,174
| +2% | +$36.5K |
2024 Q4
6 quarters
|
|
18
Methode Electronics
MEI
$543M
| $2.74M | 1.85% |
144,272
+3,630
| +3% | +$37.5K |
2026 Q1
1 quarter
|
|
19
Vera Bradley
VRA
$157M
| $2.66M | 1.8% |
684,766
-149,341
| -18% | -$551K |
2024 Q4
6 quarters
|
|
20
Mammoth Energy Services
TUSK
$135M
| $2.63M | 1.77% |
807,804
+207,999
| +35% | +$609K |
2026 Q1
1 quarter
|
|
21
MaxCyte
MXCT
$103M
| $2.61M | 1.76% |
2,125,752
+793,559
| +60% | +$791K |
2026 Q1
1 quarter
|
|
22
Cato Corp
CATO
$47.6M
| $2.52M | 1.7% |
778,940
+12,115
| +2% | +$36.9K |
2024 Q4
6 quarters
|
|
|
23
KVH Industries
KVHI
$115M
| $2.48M | 1.67% |
249,907
-164,831
| -40% | -$1.58M |
2024 Q4
6 quarters
|
|
24
Kelly Services Class A
KELYA
$538M
| $2.36M | 1.59% |
192,461
+22,512
| +13% | +$234K |
2026 Q1
1 quarter
|
|
25
Medifast
MED
$130M
| $2.36M | 1.59% |
222,576
+3,513
| +2% | +$40.5K |
2025 Q1
5 quarters
|
|
Similar funds
VIS
NCM
PSB
PPWM
AAG
9C
MCM
PAYA
Peapod Lane Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Peapod Lane Capital held 69 positions worth $148M, up 22% from $122M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Peapod Lane Capital deployed $6.69M of net new capital in Q2 2026, opening 7 new positions and adding to 42 existing holdings. Its largest new stake was enGene Therapeutics: 1,102,149 shares worth $1.91M.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Commercial Vehicle Group, an estimated $2.28M trimmed.
- Peapod Lane Capital's largest Q2 2026 buy was enGene Therapeutics: 1,102,149 shares worth $1.91M.
- Peapod Lane Capital added most to Bicycle Therapeutics in Q2 2026, an estimated $1.91M increase.
- Peapod Lane Capital's biggest Q2 2026 reduction was Commercial Vehicle Group, cutting an estimated $2.28M.
- Peapod Lane Capital fully exited 4D Molecular Therapeutics in Q2 2026, selling an estimated $2.21M.
- Peapod Lane Capital's ten largest holdings make up 32% of its $148M portfolio in Q2 2026.
- Peapod Lane Capital opened 7 new positions and closed 8 in Q2 2026.
- Peapod Lane Capital's portfolio value rose 22% quarter-over-quarter to $148M.
Based on Peapod Lane Capital's 13F filing for Q2 2026, filed 27 Jul 2026.